Wan S - Search Results

1

Novel ProTide prodrugs of 5-fluoro-2'-deoxyuridine for the treatment of liver cancer.

Jiang L, Pan T, Lv Q, Yuan W, Liu X, Qu X, Luo D, Wan S, Cui S. Jiang L, et al. Among authors: wan s. Eur J Med Chem. 2023 Nov 15;260:115763. doi: 10.1016/j.ejmech.2023.115763. Epub 2023 Aug 25. Eur J Med Chem. 2023. PMID: 37659196

2

Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells.

Zhang PY, Wong IL, Yan CS, Zhang XY, Jiang T, Chow LM, Wan SB. Zhang PY, et al. Among authors: wan sb. J Med Chem. 2010 Jul 22;53(14):5108-20. doi: 10.1021/jm100035c. J Med Chem. 2010. PMID: 20560605

3

Total synthesis and bioactivity of the marine alkaloid pityriacitrin and some of its derivatives.

Zhang P, Sun X, Xu B, Bijian K, Wan S, Li G, Alaoui-Jamali M, Jiang T. Zhang P, et al. Among authors: wan s. Eur J Med Chem. 2011 Dec;46(12):6089-97. doi: 10.1016/j.ejmech.2011.10.036. Epub 2011 Oct 25. Eur J Med Chem. 2011. PMID: 22047643

4

Exploring stereoselectivity of 3-indolyl cyclopent[b]indoles: a parallel synthesis and anti-EGFR study on human cancer cells.

Fan D, Sun W, Qiu P, Wu Z, Li Y, Wan S, Jiang T, Zhang L. Fan D, et al. Among authors: wan s. Eur J Med Chem. 2014 Mar 3;74:533-40. doi: 10.1016/j.ejmech.2013.08.012. Epub 2013 Sep 4. Eur J Med Chem. 2014. PMID: 24518873

5

4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.

Zhang N, Zhang Z, Wong IL, Wan S, Chow LM, Jiang T. Zhang N, et al. Among authors: wan s. Eur J Med Chem. 2014 Aug 18;83:74-83. doi: 10.1016/j.ejmech.2014.06.016. Epub 2014 Jun 10. Eur J Med Chem. 2014. PMID: 24952376

6

Isothiouronium modification empowers pyrimidine-substituted curcumin analogs potent cytotoxicity and Golgi localization.

Tong S, Zhang M, Wang S, Yin R, Yu R, Wan S, Jiang T, Zhang L. Tong S, et al. Among authors: wan s. Eur J Med Chem. 2016 Nov 10;123:849-857. doi: 10.1016/j.ejmech.2016.07.071. Epub 2016 Jul 29. Eur J Med Chem. 2016. PMID: 27543879

7

Extending the structure-activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors.

Yang C, Wong IL, Peng K, Liu Z, Wang P, Jiang T, Jiang T, Chow LM, Wan SB. Yang C, et al. Eur J Med Chem. 2017 Jan 5;125:795-806. doi: 10.1016/j.ejmech.2016.09.070. Epub 2016 Sep 22. Eur J Med Chem. 2017. PMID: 27750197

8

Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.

Luo D, Yi Y, Peng K, Liu T, Yang J, Liu S, Zhao W, Qu X, Yu W, Gu Y, Wan S. Luo D, et al. Among authors: wan s. Eur J Med Chem. 2019 Sep 15;178:365-379. doi: 10.1016/j.ejmech.2019.06.006. Epub 2019 Jun 4. Eur J Med Chem. 2019. PMID: 31200238

9

S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer.

Zhang YH, Luo DD, Wan SB, Qu XJ. Zhang YH, et al. Pharmacol Res. 2020 May;155:104717. doi: 10.1016/j.phrs.2020.104717. Epub 2020 Feb 20. Pharmacol Res. 2020. PMID: 32088343

10

Corrigendum to "S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer" [Pharmacol Res. 155 (2020) 104717].

Zhang YH, Luo DD, Wan SB, Qu XJ. Zhang YH, et al. Pharmacol Res. 2020 Sep;159:104834. doi: 10.1016/j.phrs.2020.104834. Epub 2020 May 27. Pharmacol Res. 2020. PMID: 32473828 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,047 results

Search Page

Filters